EQRx and Ex­sci­en­tia, a pair of self-styled dis­rup­tors, team up to over­turn the drug pric­ing ap­ple cart

The biotech in­dus­try has seen no short­age of in­no­va­tion in re­cent years, but in one area — drug pric­ing — the field has been any­thing but in­no­v­a­tive. Now, two brash star­tups tak­ing dif­fer­ent roads to up­set the drug pric­ing mod­el will part­ner up to cre­ate a sort of “su­per-dis­rup­tor.”

EQRx and UK-based AI spe­cial­ist Ex­sci­en­tia will team up on a dis­cov­ery-through-com­mer­cial­iza­tion col­lab­o­ra­tion the part­ners hope will work bet­ter than the sum of its parts to bring cheap­er med­i­cines to pa­tients faster, the com­pa­nies said Thurs­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER